From Seekingalpha · SA Transcripts · · 30s
Boule Diagnostics Q3 Earnings Drop
Boule Diagnostics AB reported a 24.4% sales decline in Q3 2026 due to component shortages and weak demand.
In brief
Boule Diagnostics AB reported a 24.4% sales decline in Q3 2026 due to component shortages and weak demand. Boule Diagnostics AB's Q3 2026 sales dropped 24.4% from component shortages and weak demand. Originally reported by Seekingalpha.
Q3 2026 Earnings Call
Boule Diagnostics AB held its Q3 2026 earnings call on October 23, 2026.
Sales Decline
Net sales decreased by 24.4% with organic decline of 19.4% and currency effects of 5%.
Component Shortages
Component shortages limited instrument deliveries, affecting 3-part human and 4-part veterinary instruments.
The main idea
Boule Diagnostics AB's Q3 2026 sales dropped 24.4% from component shortages and weak demand.
